<DOC>
	<DOCNO>NCT02809898</DOCNO>
	<brief_summary>Our study aim evaluate role ct-DNA PBMC biomarkers treatment biliary tract cancer .</brief_summary>
	<brief_title>The Role ctDNA PBMC Treatment Biliary Tract Cancer</brief_title>
	<detailed_description>Biliary cancer rank fifth gastrointestinal malignant cancer . Epidemiological survey show significant increase trend recent year . How make early diagnosis bile duct cancer well prognostic evaluation efficacy monitoring , become hotspot . `` liquid biopsy '' , meant detect cancer sequence DNA drop person 's blood . It may detect cancer early , even symptom arise , cell blood circulation . cf-DNA cancer patient often bear similar genetic epigenetic feature related tumor DNA . There evidence cf-DNA originate tumoral tissue . This , fact cf-DNA easily isolated circulation body fluids patient , make promise candidate non-invasive biomarker cancer . And call cf-DNA tumor ct-DNA . Peripheral blood mononuclear cell ( PBMC ) peripheral blood cell round nucleus . These cell extract whole blood use ficoll , hydrophilic polysaccharide . PBMC contain genetic material tumor may apply biomarker . This study aim evaluate role ct-DNA PBMC biomarkers treatment biliary tract cancer .</detailed_description>
	<mesh_term>Biliary Tract Neoplasms</mesh_term>
	<criteria>Patients suspect biliary tract cancer Age 18 70 year No serious organic mental illness ; Pregnancy No pathologic result Suffering malignancy time .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Biomarkers , Neoplasms</keyword>
</DOC>